You are here: Home » Companies » News
Business Standard

Strides Shasun gets US regulator nod for Ibuprofen capsules

The firm's wholly-owned subsidiary Strides Pharma Global has received nod for 200-mg Ibuprofen capsules from the US health regulator, Strides Shasun said

BS Reporter/Samreen Ahmad  |  Bengaluru 

medicine, drug, antibiotic, doctor, pharmaceuticals
(Representative image)

Pharma-major on Monday said it has received United States Food & Administration (USFDA) approval for generic pain reliever capsules. The firm's wholly-owned subsidiary has received nod for 200-mg capsules from the US health regulator, said. The nod comes after an approval cycle of almost six years.

The US over-the -counter market for the painkiller is $300 million, including a private label market of $60 million.

The Bengaluru-based company looks garner at least 20 per cent of this private label market share. The product will be commercialised in fourth quarter of the current financial year and will be manufactured at the company's oral dosage unit in Bengaluru.

The company has 74 cumulative abbreviated new application filings with of which 45 have been approved and 29 are pending approval.

First Published: Mon, April 02 2018. 17:23 IST